Dr. Reddy's Laboratories (RDY) Short Interest Ratio & Short Volume $14.35 +0.25 (+1.77%) (As of 11/19/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Dr. Reddy's Laboratories Short Interest DataDr. Reddy's Laboratories (RDY) has a short interest of 10.68 million shares. This marks a 385.45% increase in short interest from the previous month. The short interest ratio (days to cover) is 13.9, indicating that it would take 13.9 days of the average trading volume of 1.04 million shares to cover all short positions.Current Short Interest10,680,000 sharesPrevious Short Interest2,200,000 sharesChange Vs. Previous Month+385.45%Dollar Volume Sold Short$157.74 millionShort Interest Ratio13.9 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares834,700,000 sharesPercentage of Shares Shorted1.28%Today's Trading Volume844,828 sharesAverage Trading Volume1,035,020 sharesToday's Volume Vs. Average82% Short Selling Dr. Reddy's Laboratories? Sign up to receive the latest short interest report for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRDY Short Interest Over TimeRDY Days to Cover Over TimeRDY Percentage of Float Shorted Over Time Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Dr. Reddy's Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202410,680,000 shares $157.74 million +385.5%N/A13.9 $14.77 10/15/20242,200,000 shares $173.98 million +2.3%N/A12.3 $79.08 9/30/20242,150,000 shares $170.82 million -6.5%N/A11.1 $79.45 9/15/20242,300,000 shares $184.85 million +11.7%N/A10.9 $80.37 8/31/20242,060,000 shares $171.95 million -9.3%N/A9 $83.47 8/15/20242,270,000 shares $185.07 million +20.1%N/A9.1 $81.53 Get the Latest News and Ratings for RDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,890,000 shares $153.71 million -2.6%N/A6.9 $81.33 7/15/20241,940,000 shares $156.05 million -2.5%N/A7.3 $80.44 6/30/20241,990,000 shares $151.62 million +5.3%N/A8 $76.19 6/15/20241,890,000 shares $135.80 million +61.5%N/A7.9 $71.85 5/31/20241,170,000 shares $80.33 million +20.1%N/A5.2 $68.66 5/15/2024974,400 shares $67.86 million +12.3%N/A4.8 $69.64 4/30/2024867,900 shares $63.76 million +15.6%N/A4.6 $73.47 4/15/2024751,000 shares $53.45 million +20.0%N/A3.9 $71.17 3/31/2024625,800 shares $45.90 million -11.8%N/A3.2 $73.35 3/15/2024709,300 shares $53.36 million +9.4%N/A3.5 $75.23 2/29/2024648,100 shares $49.79 million -6.6%N/A2.8 $76.83 2/15/2024693,500 shares $52.03 million -9.7%N/A2.9 $75.02 1/31/2024768,000 shares $55.35 million +4.3%N/A3.2 $72.08 1/15/2024736,100 shares $51.07 million -13.4%N/A2.9 $69.38 12/31/2023849,500 shares $59.11 million -22.8%N/A3.3 $69.58 12/15/20231,100,000 shares $73.29 million -5.2%N/A4.1 $66.63 11/30/20231,160,000 shares $81.08 million +9.4%N/A4.4 $69.90 11/15/20231,060,000 shares $69.64 million -16.5%N/A4.3 $65.70 10/31/20231,270,000 shares $82.72 million +4.1%N/A4.3 $65.13 10/15/20231,220,000 shares $81.04 million +10.9%N/A4.1 $66.43 9/30/20231,100,000 shares $73.56 million -36.8%N/A3.8 $66.87 9/15/20231,740,000 shares $121.54 million +8.1%N/A6.3 $69.85 8/31/20231,610,000 shares $109.44 million -6.9%N/A6 $67.98 8/15/20231,730,000 shares $122.95 million +32.1%1.0%6.6 $71.07 7/31/20231,310,000 shares $89.97 million -4.4%0.8%5.4 $68.68 7/15/20231,370,000 shares $84.80 million -23.5%0.8%5.9 $61.90 6/30/20231,790,000 shares $112.99 million -4.3%N/A7.5 $63.13 6/15/20231,870,000 shares $111.07 million -1.1%N/A7.6 $59.40 5/31/20231,890,000 shares $104.31 million +3.3%N/A7.6 $55.19 5/15/20231,830,000 shares $101.20 million -3.7%N/A7.6 $55.30 4/30/20231,900,000 shares $114.87 million +7.3%N/A9 $60.46 4/15/20231,770,000 shares $106.36 million No ChangeN/A8.8 $60.09 3/31/20231,770,000 shares $100.77 million +29.2%N/A9.1 $56.93 3/15/20231,370,000 shares $73.13 million +1.5%N/A7.5 $53.38Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 2/28/20231,350,000 shares $70.54 million +6.3%N/A7.9 $52.25 2/15/20231,270,000 shares $70.09 million +7.6%N/A6.9 $55.19 1/31/20231,180,000 shares $63.48 million -12.6%N/A5.9 $53.80 1/15/20231,350,000 shares $72.36 million +16.4%N/A6.3 $53.60 12/30/20221,160,000 shares $60.03 million No ChangeN/A5.5 $51.75 12/15/20221,160,000 shares $62.08 million -8.7%N/A5.3 $53.52 11/30/20221,270,000 shares $71.51 million -2.3%N/A5.3 $56.31 11/15/20221,300,000 shares $71.54 million -19.8%N/A5.6 $55.03 10/31/20221,620,000 shares $87.98 million +3.9%N/A6.9 $54.31 10/15/20221,560,000 shares $80.71 million -12.9%N/A7.3 $51.74 9/30/20221,790,000 shares $93.69 million +5.9%N/A8 $52.34 9/15/20221,690,000 shares $87.39 million +13.4%N/A8 $51.71 8/31/20221,490,000 shares $77.91 million +27.4%N/A7.2 $52.29 8/15/20221,170,000 shares $62.74 million +7.3%N/A5.7 $53.62 7/31/20221,090,000 shares $56.14 million -16.2%N/A5.5 $51.50 7/15/20221,300,000 shares $74.33 million No ChangeN/A6.6 $57.18 6/30/20221,300,000 shares $72.01 million -26.6%N/A6.8 $55.39 6/15/20221,770,000 shares $99.35 million -13.2%N/A8.4 $56.13 5/31/20222,040,000 shares $112.91 million +9.7%N/A10 $55.35 5/15/20221,860,000 shares $94.60 million +35.8%N/A8.6 $50.86 4/30/20221,370,000 shares $73.54 million +8.7%N/A6.5 $53.68 4/15/20221,260,000 shares $70.57 million +26.8%N/A6.1 $56.01 3/31/2022994,100 shares $55.40 million +1.4%N/A5 $55.73 3/15/2022980,600 shares $50.49 million +5.4%N/A6.1 $51.49 2/28/2022930,000 shares $49.68 million +2.6%N/A6 $53.42 2/15/2022906,500 shares $51.24 million +46.0%N/A6.6 $56.52 1/31/2022621,000 shares $35.71 million -13.4%N/A5.2 $57.50 1/15/2022717,300 shares $44.93 million +3.2%N/A6 $62.64 12/31/2021694,800 shares $45.45 million -2.7%N/A5.6 $65.41 12/15/2021713,700 shares $43.15 million -43.8%N/A5.1 $60.46 11/30/20211,270,000 shares $79.30 million -3.1%N/A9.7 $62.44 11/15/20211,310,000 shares $85.65 million +5.7%N/A10.4 $65.38 10/29/20211,240,000 shares $76.19 million -3.1%N/A9.9 $61.44 10/15/20211,280,000 shares $84.49 million +31.2%N/A9.9 $66.01 9/30/2021975,400 shares $63.54 million -13.7%N/A8 $65.14 9/15/20211,130,000 shares $76.13 million -1.7%N/A10 $67.37 8/31/20211,150,000 shares $73.84 million -1.7%N/A10 $64.21 8/13/20211,170,000 shares $73.37 million +17.6%0.7%10.6 $62.71 7/30/2021995,200 shares $62.25 million +3.4%0.6%8.5 $62.55 7/15/2021962,700 shares $69.83 million -22.4%0.6%8.4 $72.54 6/30/20211,240,000 shares $91.15 million +4.2%0.8%10 $73.51 6/15/20211,190,000 shares $87.71 million -10.5%0.7%8.5 $73.71 5/28/20211,330,000 shares $94.92 million +6.4%0.8%9 $71.37 5/14/20211,250,000 shares $90.68 million -3.9%N/A7 $72.54 4/30/20211,300,000 shares $89.65 million +26.2%N/A7 $68.96 4/15/20211,030,000 shares $64.97 million -6.4%N/A4.7 $63.08 3/31/20211,100,000 shares $67.23 million -17.3%N/A5.1 $61.12 3/15/20211,330,000 shares $81.04 million +3.9%N/A6.6 $60.93 2/26/20211,280,000 shares $77.58 million +10.3%N/A6.6 $60.61 2/12/20211,160,000 shares $76.77 million +6.4%N/A6.4 $66.18Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 1/29/20211,090,000 shares $72.01 million -1.8%N/A6.2 $66.06 1/15/20211,110,000 shares $79.93 million +31.3%N/A7 $72.01 12/31/2020845,300 shares $59.80 million +8.0%N/A5.3 $70.74 12/15/2020782,900 shares $53.25 million -3.9%N/A4.4 $68.02 11/30/2020814,800 shares $53.26 million +2.3%N/A4.3 $65.37 11/15/2020796,300 shares $51.24 million -10.4%N/A4.2 $64.35 10/30/2020888,300 shares $58.83 million -0.5%N/A5 $66.23 10/15/2020892,400 shares $62.30 million -15.8%N/A5.2 $69.81 9/30/20201,060,000 shares $73.73 million -26.9%N/A6.1 $69.56 9/15/20201,450,000 shares $87.71 million -2.0%N/A9.1 $60.49 8/31/20201,480,000 shares $86.09 million -2.6%N/A9 $58.17 8/14/20201,520,000 shares $92.40 million -2.6%N/A8.7 $60.79 7/31/20201,560,000 shares $94.85 million +4.7%N/A8 $60.80 7/15/20201,490,000 shares $78.98 million No ChangeN/A7.4 $53.01 6/30/20201,490,000 shares $79.01 million +3.5%N/A6.6 $53.03 6/15/20201,440,000 shares $75.46 million -5.3%N/A6 $52.40 5/29/20201,520,000 shares $81.23 million No ChangeN/A6.3 $53.44 5/15/20201,520,000 shares $75.48 million +20.6%N/A6.5 $49.66 4/30/20201,260,000 shares $64.80 million -6.0%N/A5.6 $51.43 4/15/20201,340,000 shares $66.12 million +3.1%N/A5.6 $49.34 3/31/20201,300,000 shares $67.37 million +13.1%N/A5.7 $51.82 3/13/20201,149,000 shares $53.85 million -0.1%0.9%6.3 $46.87 2/28/20201,150,000 shares $42.18 million -0.9%0.7%6.3 $36.68 2/14/20201,160,000 shares $47.75 million -8.7%0.7%6.2 $41.16 1/31/20201,270,000 shares $54.71 million +0.8%0.8%7 $43.08 1/15/20201,260,000 shares $56.11 million -2.3%0.8%7 $44.53 12/31/20191,290,000 shares $54.18 million -6.5%0.8%8 $42.00 RDY Short Interest - Frequently Asked Questions What is Dr. Reddy's Laboratories' current short interest? Short interest is the volume of Dr. Reddy's Laboratories shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 10,680,000 shares of RDY short. Learn More on Dr. Reddy's Laboratories' current short interest. What is a good short interest ratio for Dr. Reddy's Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RDY shares currently have a short interest ratio of 14.0. Learn More on Dr. Reddy's Laboratories's short interest ratio. Is Dr. Reddy's Laboratories' short interest increasing or decreasing? Dr. Reddy's Laboratories saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 10,680,000 shares, an increase of 385.5% from the previous total of 2,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dr. Reddy's Laboratories' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Dr. Reddy's Laboratories: Takeda Pharmaceutical Company Limited (0.19%), BioNTech SE (0.84%), Teva Pharmaceutical Industries Limited (1.60%), BeiGene, Ltd. (1.12%), Viatris Inc. (2.09%), Summit Therapeutics Inc. (2.31%), Moderna, Inc. (10.02%), Genmab A/S (0.37%), Vaxcyte, Inc. (7.16%), Catalent, Inc. (4.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Dr. Reddy's Laboratories stock? Short selling RDY is an investing strategy that aims to generate trading profit from Dr. Reddy's Laboratories as its price is falling. RDY shares are trading up $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dr. Reddy's Laboratories? A short squeeze for Dr. Reddy's Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RDY, which in turn drives the price of the stock up even further. How often is Dr. Reddy's Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDY, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Takeda Pharmaceutical Short Interest BioNTech Short Interest Teva Pharmaceutical Industries Short Interest BeiGene Short Interest Viatris Short Interest Summit Therapeutics Short Interest Moderna Short Interest Genmab A/S Short Interest Vaxcyte Short Interest Catalent Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:RDY) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
